MDR-1 and MRP overexpression have been associated ... Annamycin is under development for the treatment of drug-resistant breast cancer, and like Incel, it has the potential to be used in treating ...

The founders of Bugworks Research are attempting to bring to market a new class of antibiotics--a first in almost half a ...

which target multi-drug-resistant (MDR) Gram-negative bacteria. The collaborative project between Infex and JLU will focus on optimizing manufacturing processes and advancing lead compounds ...

The company will publish its Full-Year 2024 financial results on March 26, 2025. On the reporting date, BioVersys will issue a press release at 7:00 AM CET.

The European Association of Medical Device Notified Bodies, also known as Team NB, has proposed the issuance of a conditional ...